|
인쇄하기
취소
|
KFDA approves GSK’s Paxil CR for use in PMDD and social anxiety disorder
Published: 2004-08-19 06:58:00
Updated: 2004-08-19 06:58:00
The Korea Food and Drug Administration said it has approved GSK’s Paxil (paroxetine HCl) controlled-release tablets for the treatment of premenstrual dysphoric disorder (PMDD) and social anxiety disorder in addition to initial indications, such as depression and panic disorder.
GSK officials said, “The KFDA approval on Paxil CR tablet for the treatment of such additional disorders demonstra...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.